首页> 外文期刊>Respirology : >Can non-invasive positive pressure ventilation prevent endotracheal intubation in acute lung injury/acute respiratory distress syndrome? A meta-analysis
【24h】

Can non-invasive positive pressure ventilation prevent endotracheal intubation in acute lung injury/acute respiratory distress syndrome? A meta-analysis

机译:无创正压通气能否预防急性肺损伤/急性呼吸窘迫综合征的气管插管?荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

The role of non-invasive positive pressure ventilation (NIPPV) in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is controversial. The aim of this study was to investigate whether NIPPV could prevent endotracheal intubation and decrease mortality rate in patients with ALI/ARDS. Randomized controlled trials (RCT) which reported endotracheal intubation and mortality rate in patients with ALI/ARDS treated by NIPPV were identified in Pubmed, Medline, Embase, Central Cochrane Controlled Trials Register, Chinese National Knowledge Infrastructure, reference lists and by manual searches. Fixed- and random-effects models were used to calculate pooled relative risks. This meta-analysis included six RCT involving 227 patients. The results showed that endotracheal intubation rate was lower in NIPPV (95% confidence interval (CI): 0.44-0.80, z = 3.44, P = 0.0006), but no significant difference was found either in intensive care unit (ICU) mortality (95% CI: 0.45-1.07, z = 1.65, P = 0.10) or in hospital mortality (95% CI: 0.17-1.58, z = 1.16, P = 0.25).Only two studies discussed the aetiology of ALI/ARDS as pulmonary or extra-pulmonary, and neither showed statistical heterogeneity (I2 = 0%, χ2 = 0.31, P = 0.58), nor a significant difference in endotracheal intubation rate (95% CI: 0.35-9.08, z = 0.69, P = 0.49). In conclusion, the early use of NIPPV can decrease the endotracheal intubation rate in patients with ALI/ARDS, but does not change the mortality of these patients.
机译:无创正压通气(NIPPV)在急性肺损伤(ALI)/急性呼吸窘迫综合征(ARDS)中的作用引起争议。这项研究的目的是调查NIPPV是否可以预防ALI / ARDS患者的气管插管并降低死亡率。在Pubmed,Medline,Embase,中央Cochrane对照试验注册簿,中国国家知识基础设施,参考文献列表和通过手动搜索中确定了报告NIPPV治疗的ALI / ARDS患者气管插管和死亡率的随机对照试验(RCT)。固定效应和随机效应模型用于计算汇总的相对风险。这项荟萃分析包括6项RCT,涉及227名患者。结果显示,NIPPV的气管插管率较低(95%置信区间(CI):0.44-0.80,z = 3.44,P = 0.0006),但重症监护病房(ICU)的死亡率均无显着差异(95) %CI:0.45-1.07,z = 1.65,P = 0.10)或住院死亡率(95%CI:0.17-1.58,z = 1.16,P = 0.25)。只有两项研究讨论了ALI / ARDS的病因是肺部疾病或肺外,且均未显示统计学异质性(I2 = 0%,χ2= 0.31,P = 0.58),气管插管率也无显着差异(95%CI:0.35-9.08,z = 0.69,P = 0.49)。总之,早期使用NIPPV可以降低ALI / ARDS患者的气管插管率,但不会改变这些患者的死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号